Ventas (VTR)
(Delayed Data from NYSE)
$42.64 USD
+0.41 (0.97%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $42.62 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Company Summary
Chicago, IL-based Ventas, Inc. is a healthcare real estate investment trust (REIT) that is engaged in acquisition, ownership and leasing of senior housing communities, outpatient medical buildings, research centers, hospitals and other healthcare facilities located in North America and the U.K.
This S&P 500 company had owned or had investments in nearly 1,400 properties, as of Dec 31, 2023.
As of Dec 31, 2023, Ventas operated through three reportable segments, namely senior housing operating portfolio or SHOP (generated 38% of annual adjusted NOI in fourth-quarter 2023), outpatient medical and research portfolio (32%) and triple-net leased (...
Company Summary
Chicago, IL-based Ventas, Inc. is a healthcare real estate investment trust (REIT) that is engaged in acquisition, ownership and leasing of senior housing communities, outpatient medical buildings, research centers, hospitals and other healthcare facilities located in North America and the U.K.
This S&P 500 company had owned or had investments in nearly 1,400 properties, as of Dec 31, 2023.
As of Dec 31, 2023, Ventas operated through three reportable segments, namely senior housing operating portfolio or SHOP (generated 38% of annual adjusted NOI in fourth-quarter 2023), outpatient medical and research portfolio (32%) and triple-net leased (NNN) properties (30%).
In the SHOP segment, Ventas owns and invests in senior housing communities across the United States and Canada. The senior housing communities in its SHOP segment include independent living communities, assisted living communities, memory care communities and continuing care retirement communities.
In the outpatient medical and research portfolio segment, Ventas acquires, owns, develops, leases and manages outpatient medical buildings and research centers across the United States.
Ventas offers outpatient medical building and research center management, leasing, marketing, facility development and advisory services to well-rated hospitals and health systems and universities, academic medical centers, biotech and other similar companies in the United States through its ownership interest in PMB Real Estate Services LLC and the company’s subsidiary, Lillibridge Healthcare Services, Inc.
In the triple-net leased properties segment, Ventas invests in and owns senior housing communities, skilled nursing facilities, long-term acute care facilities, freestanding inpatient rehabilitation facilities and other healthcare facilities in the United States and the United Kingdom.
Note: All EPS numbers presented in this report represents funds from operations (FFO) per share. FFO, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.
General Information
Ventas, Inc
353 N. CLARK STREET SUITE 3300
CHICAGO, IL 60654
Phone: 877-483-6827
Fax: 302-655-5049
Web: http://www.ventasreit.com
Email: bj.grant@ventasreit.com
Industry | REIT and Equity Trust - Other |
Sector | Finance |
Fiscal Year End | December |
Last Reported Quarter | 3/31/2024 |
Earnings Date | 5/1/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.75 |
Current Year EPS Consensus Estimate | 3.15 |
Estimated Long-Term EPS Growth Rate | 5.70 |
Earnings Date | 5/1/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 42.23 |
52 Week High | 50.99 |
52 Week Low | 39.33 |
Beta | 1.26 |
20 Day Moving Average | 2,218,986.75 |
Target Price Consensus | 50.71 |
4 Week | -2.89 |
12 Week | -10.12 |
YTD | -14.45 |
4 Week | 1.57 |
12 Week | -12.22 |
YTD | -19.53 |
Shares Outstanding (millions) | 404.05 |
Market Capitalization (millions) | 17,228.64 |
Short Ratio | NA |
Last Split Date | 10/26/1994 |
Dividend Yield | 4.22% |
Annual Dividend | $1.80 |
Payout Ratio | 0.60 |
Change in Payout Ratio | -0.04 |
Last Dividend Payout / Amount | 3/28/2024 / $0.45 |
Fundamental Ratios
P/E (F1) | 13.54 |
Trailing 12 Months | 14.21 |
PEG Ratio | 2.37 |
vs. Previous Year | 4.11% |
vs. Previous Quarter | 1.33% |
vs. Previous Year | 10.74% |
vs. Previous Quarter | 1.27% |
Price/Book | 1.80 |
Price/Cash Flow | 13.05 |
Price / Sales | 3.83 |
3/31/24 | NA |
12/31/23 | -0.41 |
9/30/23 | 0.05 |
3/31/24 | NA |
12/31/23 | -0.17 |
9/30/23 | 0.02 |
3/31/24 | NA |
12/31/23 | 0.51 |
9/30/23 | 0.43 |
3/31/24 | NA |
12/31/23 | 0.51 |
9/30/23 | 0.43 |
3/31/24 | NA |
12/31/23 | -0.91 |
9/30/23 | 0.11 |
3/31/24 | NA |
12/31/23 | -0.91 |
9/30/23 | 0.11 |
3/31/24 | NA |
12/31/23 | -2.57 |
9/30/23 | -1.95 |
3/31/24 | NA |
12/31/23 | 23.72 |
9/30/23 | 24.54 |
3/31/24 | NA |
12/31/23 | NA |
9/30/23 | NA |
3/31/24 | NA |
12/31/23 | 1.41 |
9/30/23 | 1.36 |
3/31/24 | NA |
12/31/23 | 58.57 |
9/30/23 | 57.55 |